Abstract
Introduction
At some point after children with early-onset scoliosis (EOS) undergo implantation of a distraction construct to control deformity and promote growth, a decision is made to discontinue lengthening. The purpose of this study was to evaluate surgeon indications for discontinuation of a lengthening program and to evaluate patient outcomes.
Methods
As a part of a multicenter database, surgeons prospectively completed a questionnaire at the completion of growth-friendly treatment. Surgeon indications for discontinuation included patient age, pain/functional status, implant status, and spinal deformity parameters. Patient demographics, scoliosis type, deformity parameters, and length of time in a growing program were queried. Patients were treated with a final fusion or observation, and rate of secondary surgeries was analyzed.
Results
Questionnaires were completed on 121 patients (61% female). EOS etiology was 31% neuromuscular, 43% congenital, 16% idiopathic, and 10% syndromic. Average age at initiation of growing program was 6.8 ± 3.1 years, and average age at discontinuation was 12.7 ± 2.5 years. The most commonly cited indications for discontinuation of a lengthening program included bone age/skeletal maturity (n = 46), patient age (n = 33), and diminishing returns with expansions (n = 33). A larger coronal Cobb angle was found in patients who underwent definitive fusion (65°) when compared with continued observation (55°, p = 0.001). Twenty-nine (24%) patients were initially treated with observation after completion of a growing construct. In this subgroup, at a minimum of 2 years’ (average 3.8 years’) follow-up, 26/29 (90%) patients remained stable with observation alone; whereas, three (10%) underwent delayed final fusion surgery.
Conclusions
The most common surgeon-cited indications for discontinuation of a lengthening program in EOS patients are skeletal maturity and patient age. The majority of patients (76%) underwent definitive spinal fusion after discontinuation of a lengthening program; whereas, those treated with observation alone had a survivorship of 90% at a minimum follow-up of two years.
Similar content being viewed by others
References
Williams BA, Matsumoto H, McCalla DJ et al (2014) Development and initial validation of the Classification of Early-Onset Scoliosis (C-EOS). J Bone Jt Surg Am 96:1359–1367
Fletcher ND, McClung A, Rathjen KE et al (2012) Serial casting as a delay tactic in the treatment of moderate-to-severe early-onset scoliosis. J Pediatr Orthop 32:664–671
Akbarnia BA, Yazici M, Thompson GH (2011) The growing spine: management of spinal disorders in young children. Springer, Heidelberg
Smith JT (2007) The use of growth-sparing instrumentation in pediatric spinal deformity. Orthop Clin N Am 38(547–52):vii
McCarthy RE, McCullough FL (2015) Shilla growth guidance for early-onset scoliosis: results after a minimum of five years of follow-up. J Bone Jt Surg Am 97:1578–1584
Campbell RM Jr, Smith MD, Mayes TC et al (2004) The effect of opening wedge thoracostomy on thoracic insufficiency syndrome associated with fused ribs and congenital scoliosis. J Bone Jt Surg Am 86:1659–1674
Akbarnia BA, Marks DS, Boachie-Adjei O et al (2005) Dual growing rod technique for the treatment of progressive early-onset scoliosis: a multicenter study. Spine 30:S46–S57
Hickey BA, Towriss C, Baxter G et al (2014) Early experience of MAGEC magnetic growing rods in the treatment of early onset scoliosis. Eur Spine J 23(suppl 1):S61–S65
Trobisch PD, Ducoffe AR, Lonner BS, Errico TJ (2013) Choosing fusion levels in adolescent idiopathic scoliosis. J Am Acad Orthop Surg 21:519–528
Yazici M, Emans J (2009) Fusionless instrumentation systems for congenital scoliosis: expandable spinal rods and vertical expandable prosthetic titanium rib in the management of congenital spine deformities in the growing child. Spine 34:1800–1807
Pizones J, Martin-Buitrago MP, Sanchez Marquez JM et al (2018) Decision making of graduation in patients with early-onset scoliosis at the end of distraction-based programs: risks and benefits of definitive fusion. Spine Deform 6:308–313
Sankar WN, Skaggs DL, Yazici M et al (2011) Lengthening of dual growing rods and the law of diminishing returns. Spine 36:806–809
Cahill PJ, Marvil S, Cuddihy L et al (2010) Autofusion in the immature spine treated with growing rods. Spine 35:E1199–E1203
Flynn JM, Tomlinson LA, Pawelek J et al (2013) Growing-rod graduates: lessons learned from ninety-nine patients who completed lengthening. J Bone Jt Surg Am 95:1745–1750
Sawyer JR, de Mendonca RG, Flynn TS et al (2016) Complications and radiographic outcomes of posterior spinal fusion and observation in patients who have undergone distraction-based treatment for early onset scoliosis. Spine Deform 4:407–412
Jain A, Sponseller PD, Flynn JM et al (2016) Avoidance of “final” surgical fusion after growing-rod treatment for early-onset scoliosis. J Bone Jt Surg Am 98:1073–1078
Kocyigit IA, Olgun ZD, Demirkiran HG et al (2017) Graduation protocol after growing-rod treatment: removal of implants without new instrumentation is not a realistic approach. J Bone Jt Surg Am 99:1554–1564
Hosseini P, Pawelek JB, Nguyen S et al (2017) Rod fracture and lengthening intervals in traditional growing rods: is there a relationship? Eur Spine J 26:1690–1695
Erwin WD, Dickson JH, Harrington PR (1980) Clinical review of patients with broken Harrington rods. J Bone Jt Surg Am 62:1302–1307
Sturz H, Hinterberger J, Matzen K, Plitz W (1979) Damage analysis of the Harrington rod fracture after scoliosis operation. Arch Orthop Trauma Surg 95:113–122
Dubousset J, Herring JA, Shufflebarger H (1989) The crankshaft phenomenon. J Pediatr Orthop 9:541–550
Sanders JO, Little DG, Richards BS (1997) Prediction of the crankshaft phenomenon by peak height velocity. Spine 22:1352–1356 (discussion 1356–7)
Shufflebarger HL, Clark CE (1991) Prevention of the crankshaft phenomenon. Spine 16:S409–S411
Funding
No funding was used for data acquisition, analysis, or for manuscript writing or preparation.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
RFM (none), WRB (none), TSH (none), JTS (personal fees from Biomet, Ellipse, Globus, Spineguard, and Synthes, outside the submitted work; in addition, he has a patent DePuy with royalties paid), JBE (personal fees from Biomet, Medtronic, and Synthes, outside the submitted work; in addition, he has a patent DePuy with royalties paid), AS (personal fees from DePuy, Ethicon, Globus, NuVasive, Stryker, and Zimmer Biomet, outside the submitted work; in addition, he has a patent NuVasive with royalties paid, and a patent Zimmer Biomet with royalties paid), SG (personal fees from Decision Support in Medicine, Medtronic, and Mighty Oak Medical, outside the submitted work), JRS (personal fees from DePuy and NuVasive; other from Mosby and Wolters Kluwer Health, outside the submitted work), JMP (personal fees from DePuy, NuVasive, and Zimmer, outside the submitted work); Children’s Spine Study Group (none).
Ethical approval
IRB approval: The data used for this study were from the Children’s Spine Foundation Registry. All participating sites in this registry maintain IRB approval for input of patient information.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Murphy, R.F., Barfield, W.R., St Hilaire, T. et al. Prospectively collected surgeon indications for discontinuation of a lengthening program for early-onset scoliosis. Spine Deform 8, 129–133 (2020). https://doi.org/10.1007/s43390-020-00048-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43390-020-00048-x